Vitamin C [EPC]

Vitamin C [EPC] was reported 416972 times

Drugs of the Vitamin C [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5825 0.8122
1 SWOLLEN JOINT COUNT INCREASED 2467 0.7729
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 515 0.7710
3 PEMPHIGUS 9438 0.7541
4 RHEUMATIC FEVER 3345 0.7497
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1464 0.7309
6 DUODENAL ULCER PERFORATION 5274 0.7085
7 LUPUS VULGARIS 890 0.7063
8 C-REACTIVE PROTEIN 630 0.6796
9 RHEUMATOID FACTOR POSITIVE 3873 0.6698
10 FACET JOINT SYNDROME 2037 0.6250
11 HAND DEFORMITY 7977 0.6076
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1111 0.5357
13 HELICOBACTER INFECTION 5362 0.5212
14 DISLOCATION OF VERTEBRA 1151 0.5042
15 X-RAY ABNORMAL 865 0.4832
16 MUSCLE INJURY 3870 0.4666
17 SYNOVITIS 8054 0.4462
18 RETINITIS 767 0.4436
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2852 0.4387
20 C-REACTIVE PROTEIN ABNORMAL 2800 0.4361
21 FOLLICULITIS 4417 0.4208
22 GLOSSODYNIA 9179 0.4096
23 PERIPHERAL VENOUS DISEASE 1672 0.4090
24 PERICARDITIS 6638 0.3947
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 923 0.3731
26 BLOOD PRESSURE DIASTOLIC ABNORMAL 934 0.3668
27 SERONEGATIVE ARTHRITIS 381 0.3325
28 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 755 0.3274
29 BONE EROSION 1095 0.3093
30 SYSTEMIC LUPUS ERYTHEMATOSUS 10659 0.3000
31 WOUND 8267 0.2955
32 CONTRAINDICATED PRODUCT ADMINISTERED 8213 0.2710
33 BURSITIS 3139 0.2585
34 BREAST CANCER STAGE III 1604 0.2474
35 ENTHESOPATHY 387 0.2473
36 DRUG TOLERANCE DECREASED 695 0.2472
37 TEMPERATURE REGULATION DISORDER 548 0.2457
38 GRIP STRENGTH DECREASED 2124 0.2411
39 JOINT DESTRUCTION 374 0.2404
40 PORPHYRIA ACUTE 344 0.2397
41 JOINT RANGE OF MOTION DECREASED 3211 0.2392
42 LIP DRY 2121 0.2333
43 ONYCHOMADESIS 949 0.2259
44 IRRITABLE BOWEL SYNDROME 4730 0.2204
45 HYPERCHOLESTEROLAEMIA 2129 0.2203
46 WOUND INFECTION 2370 0.2162
47 LIVE BIRTH 1764 0.2107
48 RHEUMATOID NODULE 558 0.2024
49 ONYCHOMYCOSIS 880 0.2004
50 FIBROMYALGIA 4854 0.1995
51 ARTHROPATHY 10619 0.1909
52 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2003 0.1808
53 IMPAIRED HEALING 5886 0.1791
54 BLEPHAROSPASM 1101 0.1747
55 RHEUMATOID ARTHRITIS 19793 0.1742
56 AUTOIMMUNE DISORDER 1659 0.1700
57 FINGER DEFORMITY 824 0.1699
58 EXOSTOSIS 1530 0.1674
59 TENOSYNOVITIS 456 0.1652
60 PSORIATIC ARTHROPATHY 6440 0.1585
61 INFUSION RELATED REACTION 10513 0.1585
62 SCIATICA 2445 0.1532
63 FOOT DEFORMITY 1696 0.1529
64 LIVER INJURY 3595 0.1463
65 OBESITY 2320 0.1455
66 NAIL DISORDER 1262 0.1441
67 OSTEOARTHRITIS 5970 0.1407
68 HIP ARTHROPLASTY 2154 0.1405
69 LOWER RESPIRATORY TRACT INFECTION 6392 0.1404
70 TYPE 2 DIABETES MELLITUS 4665 0.1384
71 BLOOD PRESSURE DIASTOLIC DECREASED 1007 0.1363
72 MATERNAL EXPOSURE TIMING UNSPECIFIED 506 0.1346
73 HEPATIC ENZYME INCREASED 9077 0.1330
74 THERAPEUTIC PRODUCT EFFECT DECREASED 5918 0.1320
75 PULMONARY FIBROSIS 2516 0.1310
76 WALKING AID USER 862 0.1306
77 INFUSION SITE REACTION 388 0.1298
78 HYPERPARATHYROIDISM SECONDARY 323 0.1288
79 NEPHROGENIC ANAEMIA 590 0.1272
80 JOINT EFFUSION 870 0.1261
81 JOINT SWELLING 14760 0.1222
82 KNEE ARTHROPLASTY 2560 0.1215
83 DISCOMFORT 7417 0.1214
84 BLOOD PRESSURE DIASTOLIC INCREASED 561 0.1214
85 SWELLING 11180 0.1193
86 BLOOD CHOLESTEROL INCREASED 5489 0.1176
87 COELIAC DISEASE 1152 0.1173
88 JOINT DISLOCATION 1240 0.1172
89 IMMUNODEFICIENCY 1712 0.1147
90 BLOOD PRESSURE SYSTOLIC INCREASED 2236 0.1145
91 PRESCRIBED OVERDOSE 2211 0.1141
92 C-REACTIVE PROTEIN INCREASED 4124 0.1132
93 BLISTER 6248 0.1111
94 POLYARTHRITIS 584 0.1107
95 SPONDYLITIS 402 0.1104
96 NIGHT SWEATS 3542 0.1098
97 LUPUS-LIKE SYNDROME 993 0.1094
98 SYNOVIAL CYST 492 0.1064
99 PUSTULAR PSORIASIS 365 0.1062
100 STOMATITIS 6376 0.1050
101 CHRONIC SINUSITIS 394 0.1049
102 MATERNAL EXPOSURE DURING PREGNANCY 9243 0.1036
103 LOWER LIMB FRACTURE 1974 0.1026
104 FOOD ALLERGY 789 0.1021
105 RHINITIS ALLERGIC 452 0.1014
106 MUSCULOSKELETAL STIFFNESS 8849 0.1009
107 DRUG INTOLERANCE 9679 0.1001
108 BLOOD PRESSURE FLUCTUATION 2363 0.0983
109 SPINAL OSTEOARTHRITIS 853 0.0970
110 SINUSITIS 9894 0.0964
111 EAR PAIN 1872 0.0962
112 IRON DEFICIENCY 431 0.0957
113 GAIT INABILITY 3187 0.0953
114 BACK INJURY 1037 0.0953
115 INFLAMMATION 4905 0.0949
116 RED CELL DISTRIBUTION WIDTH INCREASED 392 0.0943
117 FOETAL DEATH 489 0.0942
118 INTERVERTEBRAL DISC DEGENERATION 872 0.0941
119 JOINT STIFFNESS 2434 0.0927
120 BODY TEMPERATURE DECREASED 899 0.0912
121 MOBILITY DECREASED 6499 0.0904
122 SPINAL STENOSIS 373 0.0903
123 MUSCULOSKELETAL PAIN 4699 0.0896
124 ULCER HAEMORRHAGE 606 0.0895
125 ABDOMINAL DISCOMFORT 15011 0.0894
126 SICKLE CELL ANAEMIA WITH CRISIS 1398 0.0886
127 ARTHRITIS INFECTIVE 403 0.0868
128 GESTATIONAL DIABETES 413 0.0866
129 DRUG TOLERANCE 432 0.0853
130 WHEEZING 5039 0.0849
131 TENDERNESS 885 0.0848
132 CARPAL TUNNEL SYNDROME 1187 0.0847
133 SMALL FOR DATES BABY 407 0.0819
134 MUSCLE SPASTICITY 1002 0.0815
135 SPINAL FUSION SURGERY 329 0.0810
136 HEPATIC CIRRHOSIS 1518 0.0807
137 CONTUSION 7729 0.0802
138 SKIN ABRASION 379 0.0801
139 EAR INFECTION 2125 0.0798
140 PRESCRIBED UNDERDOSE 1592 0.0797
141 NODULE 1037 0.0794
142 BRONCHIECTASIS 532 0.0789
143 CONGENITAL ANOMALY 611 0.0788
144 BASAL CELL CARCINOMA 1228 0.0786
145 TREATMENT FAILURE 6490 0.0783
146 RASH VESICULAR 378 0.0781
147 NORMAL NEWBORN 424 0.0779
148 LIVER FUNCTION TEST INCREASED 1669 0.0777
149 SERUM FERRITIN INCREASED 409 0.0775
150 UPPER RESPIRATORY TRACT INFECTION 3581 0.0774
151 EXPOSURE DURING PREGNANCY 4808 0.0773
152 TASTE DISORDER 1568 0.0772
153 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3696 0.0769
154 ALOPECIA 15108 0.0769
155 PERIPHERAL SWELLING 11846 0.0768
156 SPINAL COLUMN STENOSIS 363 0.0768
157 VITAMIN B12 DEFICIENCY 311 0.0767
158 VITAMIN D DEFICIENCY 745 0.0763
159 BLOOD URIC ACID INCREASED 440 0.0761
160 ARTHRITIS 5991 0.0761
161 OEDEMA 4123 0.0759
162 MENISCUS INJURY 463 0.0752
163 INTENTIONAL PRODUCT USE ISSUE 6575 0.0750
164 OSTEOPOROSIS 3081 0.0748
165 PREGNANCY 1497 0.0747
166 VITAMIN D DECREASED 634 0.0741
167 ILL-DEFINED DISORDER 4488 0.0738
168 HAEMATOCRIT DECREASED 1460 0.0736
169 PRODUCT LABEL CONFUSION 429 0.0735
170 WHEELCHAIR USER 327 0.0735
171 LUNG DISORDER 3543 0.0722
172 NASOPHARYNGITIS 13188 0.0715
173 POSTOPERATIVE WOUND INFECTION 479 0.0708
174 FOOT OPERATION 349 0.0704
175 RENAL CYST 559 0.0703
176 SEASONAL ALLERGY 996 0.0703
177 BREATH SOUNDS ABNORMAL 346 0.0701
178 PRE-EXISTING CONDITION IMPROVED 438 0.0701
179 CARDIAC MURMUR 605 0.0699
180 ATELECTASIS 674 0.0697
181 HAEMOLYSIS 538 0.0696
182 BLOOD TEST ABNORMAL 977 0.0695
183 POOR VENOUS ACCESS 719 0.0694
184 ANAL FISSURE 372 0.0693
185 SLEEP DISORDER 4895 0.0693
186 HIATUS HERNIA 890 0.0687
187 BODY TEMPERATURE INCREASED 1402 0.0686
188 INFLAMMATORY MARKER INCREASED 340 0.0685
189 GENERAL PHYSICAL HEALTH DETERIORATION 7889 0.0681
190 BLOOD IRON DECREASED 809 0.0681
191 DIVERTICULUM 484 0.0680
192 SLEEP APNOEA SYNDROME 1298 0.0679
193 ROTATOR CUFF SYNDROME 873 0.0679
194 GASTROINTESTINAL DISORDER 6017 0.0671
195 HEART RATE DECREASED 2354 0.0670
196 INJURY 4704 0.0669
197 BREAST CANCER STAGE II 556 0.0668
198 ULCER 1058 0.0664
199 DRY MOUTH 5382 0.0663
200 ROAD TRAFFIC ACCIDENT 2770 0.0661
201 HYPERLIPIDAEMIA 791 0.0661
202 ARTHRALGIA 27157 0.0652
203 SINUS CONGESTION 876 0.0648
204 PRE-ECLAMPSIA 307 0.0645
205 GASTROOESOPHAGEAL REFLUX DISEASE 5183 0.0643
206 RED BLOOD CELL COUNT DECREASED 1840 0.0643
207 RHINITIS 518 0.0642
208 INCREASED TENDENCY TO BRUISE 591 0.0642
209 LOCALISED INFECTION 1551 0.0641
210 BENIGN PROSTATIC HYPERPLASIA 331 0.0640
211 SKIN LACERATION 697 0.0640
212 SCOLIOSIS 396 0.0639
213 INFECTION 9231 0.0637
214 OSTEOPENIA 966 0.0636
215 IRON DEFICIENCY ANAEMIA 587 0.0635
216 BRONCHITIS 4696 0.0634
217 SQUAMOUS CELL CARCINOMA OF SKIN 382 0.0632
218 FREQUENT BOWEL MOVEMENTS 1709 0.0632
219 VENTRICULAR SEPTAL DEFECT 362 0.0632
220 NECK PAIN 3525 0.0630
221 TENDONITIS 975 0.0629
222 TOOTH INFECTION 828 0.0627
223 GINGIVAL PAIN 499 0.0626
224 BLOOD ALBUMIN DECREASED 494 0.0622
225 PREMATURE LABOUR 352 0.0622
226 TONGUE DISORDER 450 0.0621
227 POST PROCEDURAL INFECTION 504 0.0619
228 NERVE COMPRESSION 571 0.0618
229 ATRIAL SEPTAL DEFECT 516 0.0616
230 SKIN ULCER 1582 0.0611
231 MATERNAL EXPOSURE BEFORE PREGNANCY 418 0.0611
232 APHTHOUS ULCER 474 0.0611
233 PHARYNGITIS 757 0.0610
234 BLOOD CALCIUM DECREASED 686 0.0609
235 PULMONARY MASS 906 0.0608
236 BLOOD MAGNESIUM DECREASED 524 0.0607
237 HAEMOGLOBIN DECREASED 6212 0.0604
238 JOINT INJURY 1291 0.0604
239 GASTROENTERITIS VIRAL 1090 0.0603
240 HYPERSENSITIVITY 11182 0.0602
241 HYPERKERATOSIS 331 0.0599
242 TOOTH ABSCESS 609 0.0597
243 LOW BIRTH WEIGHT BABY 475 0.0597
244 INFUSION SITE SWELLING 376 0.0597
245 BODY HEIGHT DECREASED 638 0.0596
246 OXYGEN SATURATION DECREASED 3350 0.0596
247 LIVER DISORDER 2629 0.0592
248 CELLULITIS 2970 0.0589
249 THERAPY NON-RESPONDER 2647 0.0588
250 SKIN NECROSIS 305 0.0587
251 ORAL CANDIDIASIS 773 0.0586
252 TRICUSPID VALVE INCOMPETENCE 464 0.0583
253 MITRAL VALVE INCOMPETENCE 661 0.0583
254 PLATELET COUNT INCREASED 760 0.0582
255 LIGAMENT SPRAIN 576 0.0582
256 WEIGHT FLUCTUATION 609 0.0581
257 FULL BLOOD COUNT ABNORMAL 615 0.0581
258 HYPOAESTHESIA 8703 0.0581
259 END STAGE RENAL DISEASE 1060 0.0581
260 SPINAL DISORDER 548 0.0578
261 ARTERIOSCLEROSIS CORONARY ARTERY 383 0.0578
262 CYST 711 0.0572
263 PELVIC FRACTURE 446 0.0572
264 RESPIRATORY TRACT INFECTION 1489 0.0571
265 FOOT FRACTURE 1083 0.0571
266 RESPIRATORY DISORDER 1696 0.0566
267 DYSPEPSIA 5554 0.0564
268 MOUTH ULCERATION 1188 0.0563
269 CYSTITIS 1795 0.0563
270 SKIN INFECTION 632 0.0563
271 HYPERTENSION 11903 0.0561
272 RESPIRATORY RATE INCREASED 498 0.0560
273 MULTIPLE ALLERGIES 439 0.0559
274 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 958 0.0558
275 ARTHROPOD BITE 414 0.0558
276 HEPATIC STEATOSIS 1036 0.0556
277 MASS 777 0.0555
278 INTERVERTEBRAL DISC PROTRUSION 1215 0.0555
279 WEIGHT INCREASED 12429 0.0554
280 MUSCLE STRAIN 480 0.0554
281 UPPER-AIRWAY COUGH SYNDROME 454 0.0551
282 CONFUSIONAL STATE 8896 0.0550
283 PAIN IN EXTREMITY 16194 0.0549
284 PAIN 33733 0.0549
285 TENDON DISORDER 356 0.0545
286 TOOTH FRACTURE 601 0.0545
287 MUSCULOSKELETAL CHEST PAIN 837 0.0540
288 OEDEMA PERIPHERAL 6587 0.0540
289 DECUBITUS ULCER 439 0.0538
290 HYPOPHOSPHATAEMIA 398 0.0538
291 BONE DISORDER 980 0.0537
292 WRIST FRACTURE 644 0.0537
293 SPUTUM DISCOLOURED 509 0.0536
294 ADRENAL INSUFFICIENCY 651 0.0536
295 GROIN PAIN 471 0.0536
296 PRODUCTIVE COUGH 2555 0.0535
297 IMMUNOSUPPRESSION 472 0.0535
298 MYOSITIS 480 0.0534
299 HERPES ZOSTER 3068 0.0533
300 DYSPNOEA EXERTIONAL 2010 0.0533
301 HAND FRACTURE 378 0.0533
302 SPINAL COMPRESSION FRACTURE 441 0.0533
303 DIVERTICULITIS 1477 0.0532
304 MACULAR DEGENERATION 636 0.0532
305 BLOOD CALCIUM INCREASED 467 0.0532
306 HYPERCALCAEMIA 657 0.0532
307 BACK DISORDER 860 0.0528
308 ONYCHOCLASIS 364 0.0528
309 SPLENOMEGALY 619 0.0528
310 RESPIRATORY TRACT CONGESTION 837 0.0526
311 INGUINAL HERNIA 320 0.0526
312 FLANK PAIN 493 0.0525
313 POLYP 343 0.0523
314 DELIRIUM 1815 0.0522
315 GLUCOSE TOLERANCE IMPAIRED 309 0.0522
316 URINARY TRACT INFECTION 8912 0.0522
317 FEMUR FRACTURE 1615 0.0521
318 APPENDICITIS 486 0.0520
319 FAECES SOFT 378 0.0519
320 EPILEPSY 1586 0.0518
321 FOETAL GROWTH RESTRICTION 315 0.0518
322 LIMB INJURY 1402 0.0516
323 MUSCULAR WEAKNESS 5848 0.0514
324 MIGRAINE 4909 0.0514
325 SQUAMOUS CELL CARCINOMA 484 0.0514
326 RIB FRACTURE 1057 0.0513
327 WHITE BLOOD CELL COUNT INCREASED 1970 0.0513
328 NEURALGIA 1248 0.0513
329 OROPHARYNGEAL PAIN 4748 0.0512
330 RECTAL HAEMORRHAGE 2198 0.0511
331 DRUG-INDUCED LIVER INJURY 1605 0.0511
332 PANCYTOPENIA 2856 0.0511
333 CATARACT OPERATION 303 0.0510
334 DISABILITY 1006 0.0508
335 BREAST MASS 341 0.0507
336 HEART RATE IRREGULAR 1146 0.0507
337 CHOLECYSTITIS CHRONIC 339 0.0506
338 FATIGUE 39375 0.0505
339 MUSCULOSKELETAL DISCOMFORT 869 0.0504
340 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 855 0.0503
341 CAESAREAN SECTION 586 0.0503
342 LACERATION 471 0.0500
343 CONDITION AGGRAVATED 15221 0.0500
344 INFUSION SITE PAIN 645 0.0500
345 ORAL HERPES 977 0.0500
346 SMALL INTESTINAL OBSTRUCTION 616 0.0500
347 RENAL FAILURE CHRONIC 384 0.0499
348 HEPATITIS 1271 0.0496
349 TOOTHACHE 899 0.0496
350 PNEUMONIA 16036 0.0495
351 GAIT DISTURBANCE 9478 0.0495
352 BLOOD URINE PRESENT 939 0.0494
353 PHARYNGITIS STREPTOCOCCAL 535 0.0494
354 GASTROENTERITIS 721 0.0494
355 CATARACT 2937 0.0493
356 SINUS DISORDER 976 0.0492
357 PRODUCT USE ISSUE 9257 0.0492
358 UROSEPSIS 454 0.0492
359 FLUID RETENTION 2499 0.0491
360 BACK PAIN 11385 0.0490
361 CHOLELITHIASIS 1607 0.0490
362 GOUT 878 0.0489
363 TOOTH DISORDER 1087 0.0488
364 INFUSION SITE ERYTHEMA 412 0.0488
365 UTERINE LEIOMYOMA 357 0.0488
366 EYE INFECTION 551 0.0487
367 CARDIOMEGALY 599 0.0486
368 KIDNEY INFECTION 955 0.0486
369 MATERNAL DRUGS AFFECTING FOETUS 373 0.0486
370 PAROSMIA 367 0.0486
371 DENTAL CARIES 538 0.0486
372 RHINORRHOEA 3134 0.0484
373 HAEMORRHOIDS 945 0.0484
374 SECRETION DISCHARGE 604 0.0482
375 NASAL CONGESTION 2828 0.0481
376 PHOTOPHOBIA 904 0.0480
377 ASTHMA 5428 0.0480
378 WEIGHT DECREASED 13404 0.0480
379 ANKLE FRACTURE 743 0.0480
380 CORONARY ARTERY OCCLUSION 658 0.0479
381 SPINAL PAIN 562 0.0479
382 LOCAL SWELLING 836 0.0479
383 BLOOD PRESSURE INCREASED 7305 0.0477
384 BLOOD POTASSIUM DECREASED 1436 0.0477
385 ABDOMINAL PAIN UPPER 9827 0.0477
386 OSTEOMYELITIS 862 0.0476
387 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3386 0.0476
388 HAEMOGLOBIN ABNORMAL 306 0.0475
389 ORAL PAIN 1064 0.0475
390 MALIGNANT MELANOMA 636 0.0474
391 GASTROINTESTINAL INFECTION 425 0.0474
392 LARGE INTESTINE POLYP 328 0.0473
393 VIRAL INFECTION 1568 0.0471
394 NOCTURIA 570 0.0469
395 RASH 20456 0.0469
396 CHEST PAIN 8682 0.0468
397 TENDON RUPTURE 578 0.0468
398 FALL 15488 0.0465
399 FULL BLOOD COUNT DECREASED 937 0.0465
400 CONCUSSION 360 0.0465
401 GASTRITIS 1223 0.0464
402 BACTERIAL INFECTION 867 0.0464
403 ECCHYMOSIS 317 0.0462
404 NEPHROLITHIASIS 2119 0.0462
405 ARTERIOSCLEROSIS 434 0.0461
406 ANKYLOSING SPONDYLITIS 607 0.0460
407 GALLBLADDER DISORDER 820 0.0459
408 BLOOD SODIUM DECREASED 864 0.0458
409 BLOOD UREA INCREASED 767 0.0458
410 FOETAL EXPOSURE DURING PREGNANCY 3721 0.0457
411 OESOPHAGITIS 500 0.0457
412 CLOSTRIDIUM DIFFICILE INFECTION 997 0.0456
413 EMPHYSEMA 460 0.0456
414 ANAEMIA 8671 0.0454
415 MYASTHENIA GRAVIS 367 0.0454
416 TENDON PAIN 344 0.0454
417 PYREXIA 15715 0.0454
418 VASCULITIS 529 0.0454
419 OBSTRUCTIVE AIRWAYS DISORDER 504 0.0453
420 MICTURITION URGENCY 517 0.0452
421 TRANSFUSION 474 0.0452
422 DYSSTASIA 1317 0.0451
423 DECREASED IMMUNE RESPONSIVENESS 442 0.0450
424 OVARIAN CYST 450 0.0450
425 LYMPHOEDEMA 310 0.0448
426 TROPONIN INCREASED 341 0.0448
427 DECREASED APPETITE 10400 0.0447
428 ASTHENIA 16832 0.0447
429 EAR DISCOMFORT 457 0.0445
430 FISTULA 500 0.0444
431 GASTROINTESTINAL PAIN 489 0.0444
432 DIZZINESS POSTURAL 431 0.0444
433 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2319 0.0444
434 INFLUENZA 4949 0.0443
435 ATRIAL FLUTTER 354 0.0443
436 MALNUTRITION 496 0.0443
437 MUSCULOSKELETAL DISORDER 843 0.0442
438 COUGH 12419 0.0442
439 BALANCE DISORDER 3823 0.0442
440 LOWER GASTROINTESTINAL HAEMORRHAGE 326 0.0441
441 ACUTE RESPIRATORY FAILURE 848 0.0440
442 HERNIA 852 0.0440
443 HYPERAESTHESIA 361 0.0439
444 UPPER LIMB FRACTURE 875 0.0439
445 RASH PRURITIC 2379 0.0439
446 HAEMATOCHEZIA 2422 0.0438
447 NEUTROPHIL COUNT INCREASED 449 0.0438
448 PARAESTHESIA 6888 0.0437
449 CANDIDA INFECTION 738 0.0437
450 FURUNCLE 346 0.0436
451 ABDOMINAL DISTENSION 4555 0.0436
452 MUSCLE SPASMS 7987 0.0435
453 HYPOTHYROIDISM 1387 0.0434
454 IMMUNE SYSTEM DISORDER 572 0.0434
455 ABDOMINAL PAIN 10094 0.0433
456 AMNESIA 2816 0.0432
457 COVID-19 PNEUMONIA 511 0.0432
458 BLADDER DISORDER 429 0.0432
459 LIMB DISCOMFORT 1335 0.0431
460 CHROMATURIA 973 0.0431
461 APHONIA 601 0.0430
462 GASTROINTESTINAL INFLAMMATION 337 0.0430
463 ESCHERICHIA INFECTION 353 0.0429
464 PLEURAL EFFUSION 2607 0.0428
465 IMPAIRED WORK ABILITY 915 0.0428
466 RESTLESS LEGS SYNDROME 777 0.0427
467 INSOMNIA 11373 0.0427
468 URTICARIA 7118 0.0424
469 HYSTERECTOMY 368 0.0424
470 PETECHIAE 443 0.0424
471 SCAB 483 0.0423
472 URINE OUTPUT DECREASED 369 0.0422
473 DRY THROAT 428 0.0421
474 INCONTINENCE 445 0.0421
475 UVEITIS 571 0.0421
476 IMPAIRED QUALITY OF LIFE 605 0.0420
477 SKIN LESION 1154 0.0420
478 CLOSTRIDIUM DIFFICILE COLITIS 446 0.0420
479 PREMATURE DELIVERY 667 0.0418
480 POOR QUALITY SLEEP 900 0.0418
481 LUNG INFILTRATION 369 0.0417
482 MEMORY IMPAIRMENT 5733 0.0417
483 STAPHYLOCOCCAL INFECTION 1372 0.0416
484 HEADACHE 26069 0.0415
485 ORTHOSTATIC HYPOTENSION 724 0.0415
486 THROAT IRRITATION 1864 0.0415
487 BLOOD COUNT ABNORMAL 628 0.0414
488 GASTRIC ULCER 786 0.0413
489 LOW DENSITY LIPOPROTEIN INCREASED 320 0.0413
490 CHRONIC KIDNEY DISEASE 3139 0.0413
491 ATRIAL FIBRILLATION 4013 0.0412
492 FEELING HOT 2523 0.0411
493 INITIAL INSOMNIA 422 0.0411
494 ABSCESS 655 0.0410
495 ANAL INCONTINENCE 369 0.0410
496 HEPATOMEGALY 403 0.0410
497 SENSORY LOSS 330 0.0410
498 CONSTIPATION 8928 0.0409
499 PULMONARY HYPERTENSION 852 0.0409
500 VENTRICULAR FIBRILLATION 454 0.0408
501 HYDRONEPHROSIS 306 0.0408
502 SUPRAVENTRICULAR TACHYCARDIA 391 0.0408
503 LIVER FUNCTION TEST ABNORMAL 1186 0.0407
504 HOSPICE CARE 402 0.0407
505 BLOOD POTASSIUM INCREASED 660 0.0406
506 PSORIASIS 5302 0.0406
507 LABORATORY TEST ABNORMAL 1198 0.0406
508 FACIAL PAIN 362 0.0405
509 GLAUCOMA 780 0.0405
510 UPPER GASTROINTESTINAL HAEMORRHAGE 680 0.0404
511 LYMPHOCYTE COUNT DECREASED 713 0.0403
512 DIARRHOEA 26014 0.0403
513 PAIN IN JAW 1139 0.0402
514 ADVERSE REACTION 533 0.0402
515 FUNGAL INFECTION 1336 0.0400
516 TEMPERATURE INTOLERANCE 413 0.0400
517 FLATULENCE 2266 0.0399
518 NEPHROPATHY 372 0.0398
519 POST PROCEDURAL COMPLICATION 765 0.0398
520 LYMPHADENOPATHY 1410 0.0398
521 ALANINE AMINOTRANSFERASE INCREASED 2445 0.0398
522 DYSPNOEA 22524 0.0398
523 DEPRESSION 9028 0.0396
524 RASH ERYTHEMATOUS 1894 0.0396
525 TRANSIENT ISCHAEMIC ATTACK 1336 0.0396
526 PNEUMONIA ASPIRATION 989 0.0395
527 PARAESTHESIA ORAL 571 0.0395
528 COLITIS ULCERATIVE 1768 0.0395
529 DRY EYE 1971 0.0394
530 NERVE INJURY 439 0.0394
531 DEHYDRATION 5260 0.0394
532 FEELING COLD 1096 0.0393
533 PRODUCT ADMINISTRATION INTERRUPTED 309 0.0393
534 PERIPHERAL COLDNESS 540 0.0393
535 CORONARY ARTERY DISEASE 1190 0.0393
536 INJECTION SITE HAEMATOMA 568 0.0391
537 HYPOKALAEMIA 1805 0.0391
538 DYSPHONIA 2286 0.0390
539 ASPARTATE AMINOTRANSFERASE INCREASED 2075 0.0390
540 VENTRICULAR EXTRASYSTOLES 404 0.0389
541 ABORTION SPONTANEOUS 1558 0.0388
542 ELECTROCARDIOGRAM ABNORMAL 305 0.0388
543 DYSURIA 1430 0.0388
544 DERMATITIS CONTACT 443 0.0388
545 URINARY INCONTINENCE 1149 0.0387
546 HOT FLUSH 2920 0.0387
547 WHITE BLOOD CELL COUNT DECREASED 4197 0.0387
548 MIDDLE INSOMNIA 722 0.0386
549 HIP FRACTURE 1243 0.0386
550 HYPOPHAGIA 985 0.0385
551 POLLAKIURIA 1606 0.0385
552 HEART RATE INCREASED 3815 0.0385
553 SEPSIS 4293 0.0385
554 EPISTAXIS 2874 0.0384
555 GINGIVAL BLEEDING 524 0.0383
556 PLATELET COUNT DECREASED 4085 0.0383
557 SKIN CANCER 825 0.0383
558 VOMITING 17913 0.0381
559 PULMONARY CONGESTION 501 0.0380
560 CHOLECYSTECTOMY 434 0.0380
561 TINNITUS 1743 0.0379
562 DIZZINESS 18877 0.0378
563 SKIN DISCOLOURATION 1739 0.0378
564 THERAPY CESSATION 1942 0.0378
565 HYPERSOMNIA 1076 0.0375
566 PREMATURE BABY 1129 0.0375
567 CHILLS 4391 0.0374
568 VITREOUS FLOATERS 368 0.0374
569 EYE PAIN 2104 0.0373
570 FAECES DISCOLOURED 808 0.0372
571 COLITIS 1412 0.0372
572 THYROID DISORDER 574 0.0372
573 PERICARDIAL EFFUSION 860 0.0372
574 MUSCLE ATROPHY 471 0.0371
575 PYELONEPHRITIS 322 0.0371
576 PRURITUS 14272 0.0371
577 CONJUNCTIVITIS 687 0.0370
578 BURNING SENSATION 2594 0.0370
579 DRUG EXPOSURE DURING PREGNANCY 1257 0.0369
580 LUNG INFECTION 573 0.0368
581 INJECTION SITE PRURITUS 2468 0.0368
582 EATING DISORDER 783 0.0367
583 KNEE OPERATION 361 0.0367
584 VAGINAL DISCHARGE 371 0.0366
585 CARDIOGENIC SHOCK 526 0.0366
586 SARS-COV-2 TEST POSITIVE 484 0.0366
587 BLOOD ALKALINE PHOSPHATASE INCREASED 908 0.0365
588 TOOTH EXTRACTION 455 0.0365
589 SPINAL FRACTURE 732 0.0365
590 RENAL TUBULAR NECROSIS 358 0.0365
591 BLOOD LACTATE DEHYDROGENASE INCREASED 578 0.0364
592 SNEEZING 818 0.0364
593 ASCITES 1072 0.0364
594 SKIN DISORDER 1215 0.0364
595 SEPTIC SHOCK 1585 0.0364
596 INJECTION SITE REACTION 2506 0.0364
597 COORDINATION ABNORMAL 508 0.0364
598 PHOTOSENSITIVITY REACTION 601 0.0364
599 SCAR 623 0.0364
600 BLOOD PRESSURE ABNORMAL 722 0.0363
601 BLOOD CREATININE INCREASED 2369 0.0362
602 CHOLECYSTITIS 432 0.0362
603 NEUROPATHY PERIPHERAL 3440 0.0361
604 INTERNATIONAL NORMALISED RATIO INCREASED 1031 0.0361
605 DIARRHOEA HAEMORRHAGIC 338 0.0361
606 HEAD INJURY 1144 0.0361
607 RETCHING 770 0.0361
608 ASPIRATION 395 0.0360
609 DEFORMITY 337 0.0360
610 CHEST DISCOMFORT 3680 0.0359
611 MUCOSAL INFLAMMATION 940 0.0359
612 HYPOXIA 1264 0.0359
613 NAUSEA 28398 0.0358
614 DRUG LEVEL DECREASED 365 0.0358
615 PNEUMONIA BACTERIAL 329 0.0358
616 MUSCLE TIGHTNESS 580 0.0358
617 DEEP VEIN THROMBOSIS 2323 0.0357
618 PULMONARY THROMBOSIS 388 0.0356
619 HEAD DISCOMFORT 625 0.0353
620 ELECTROLYTE IMBALANCE 410 0.0353
621 INJECTION SITE WARMTH 724 0.0352
622 INJECTION SITE EXTRAVASATION 433 0.0351
623 BONE PAIN 2049 0.0349
624 ABASIA 863 0.0349
625 PURPURA 309 0.0349
626 HYPOMAGNESAEMIA 486 0.0349
627 RASH MACULAR 1220 0.0349
628 HAEMOPTYSIS 973 0.0348
629 MALAISE 15252 0.0347
630 HYPONATRAEMIA 1958 0.0347
631 TUBULOINTERSTITIAL NEPHRITIS 651 0.0347
632 RASH PAPULAR 778 0.0347
633 INSURANCE ISSUE 530 0.0346
634 HYPOTENSION 6947 0.0346
635 RENAL DISORDER 1612 0.0346
636 PNEUMOTHORAX 548 0.0345
637 PULMONARY EMBOLISM 3280 0.0345
638 MOVEMENT DISORDER 1108 0.0345
639 BEDRIDDEN 453 0.0344
640 PROCEDURAL PAIN 953 0.0343
641 THROMBOSIS 2759 0.0343
642 PRESYNCOPE 833 0.0342
643 RENAL PAIN 363 0.0342
644 HYPOKINESIA 497 0.0342
645 FLUSHING 3478 0.0342
646 SPINAL OPERATION 421 0.0341
647 INJECTION SITE IRRITATION 434 0.0341
648 THROMBOCYTOPENIA 3805 0.0340
649 INTESTINAL OBSTRUCTION 1281 0.0340
650 OROPHARYNGEAL DISCOMFORT 306 0.0338
651 BACTERAEMIA 402 0.0338
652 PNEUMONITIS 922 0.0338
653 INJECTION SITE DISCOLOURATION 423 0.0338
654 THERAPEUTIC RESPONSE DECREASED 2046 0.0337
655 AGEUSIA 841 0.0337
656 EYE DISORDER 1103 0.0335
657 FEELING JITTERY 639 0.0335
658 BREAST PAIN 357 0.0334
659 MEDICATION ERROR 1860 0.0334
660 ADVERSE DRUG REACTION 2999 0.0334
661 ACUTE KIDNEY INJURY 5103 0.0333
662 FEEDING DISORDER 676 0.0333
663 LEUKOCYTOSIS 603 0.0333
664 PULMONARY OEDEMA 1491 0.0333
665 SLUGGISHNESS 339 0.0332
666 ACTIVITIES OF DAILY LIVING IMPAIRED 657 0.0331
667 BLOOD TRIGLYCERIDES INCREASED 586 0.0331
668 COGNITIVE DISORDER 1544 0.0330
669 EYE DISCHARGE 343 0.0330
670 INJECTION SITE BRUISING 2630 0.0329
671 OCULAR DISCOMFORT 369 0.0328
672 DRUG ERUPTION 582 0.0328
673 LACRIMATION INCREASED 990 0.0327
674 HYPERHIDROSIS 4209 0.0326
675 ERUCTATION 632 0.0326
676 SKIN FISSURES 637 0.0326
677 LETHARGY 1875 0.0326
678 ANXIETY 9264 0.0325
679 BLOOD PRESSURE DECREASED 2161 0.0325
680 ERYTHEMA 6672 0.0324
681 EYE INFLAMMATION 309 0.0324
682 HYPOAESTHESIA ORAL 488 0.0323
683 MYELODYSPLASTIC SYNDROME 468 0.0323
684 HYPOCALCAEMIA 612 0.0323
685 COVID-19 5670 0.0323
686 HAEMATURIA 1106 0.0323
687 VERTIGO 1966 0.0322
688 CARDIAC FAILURE CONGESTIVE 2589 0.0322
689 QUALITY OF LIFE DECREASED 432 0.0322
690 DIPLOPIA 836 0.0322
691 PALPITATIONS 3769 0.0321
692 COAGULOPATHY 536 0.0321
693 INJECTION SITE NODULE 354 0.0321
694 MYALGIA 5468 0.0321
695 FRACTURE 608 0.0321
696 RENAL FAILURE ACUTE 1360 0.0320
697 DECREASED ACTIVITY 345 0.0319
698 SCRATCH 337 0.0319
699 GASTRIC DISORDER 1094 0.0318
700 PALLOR 865 0.0318
701 PRURITUS GENERALISED 687 0.0317
702 GASTROINTESTINAL HAEMORRHAGE 2651 0.0317
703 INFLUENZA LIKE ILLNESS 2609 0.0317
704 INTERNAL HAEMORRHAGE 362 0.0316
705 THIRST 566 0.0316
706 INJECTION SITE ERYTHEMA 3926 0.0316
707 DYSPHAGIA 3004 0.0316
708 GENERALISED OEDEMA 389 0.0314
709 SWELLING FACE 2042 0.0313
710 MOTOR DYSFUNCTION 318 0.0312
711 SKIN HAEMORRHAGE 462 0.0311
712 DERMATITIS ALLERGIC 390 0.0310
713 HEMIPARESIS 525 0.0310
714 MENTAL STATUS CHANGES 860 0.0309
715 SWOLLEN TONGUE 966 0.0309
716 SENSORY DISTURBANCE 495 0.0308
717 BRAIN FOG 483 0.0308
718 RENAL FAILURE 4080 0.0307
719 HAEMATOMA 795 0.0307
720 IMPAIRED DRIVING ABILITY 347 0.0305
721 FLUID OVERLOAD 443 0.0304
722 ANGINA PECTORIS 872 0.0304
723 URINARY RETENTION 1015 0.0304
724 MYOCARDIAL ISCHAEMIA 345 0.0303
725 DEVICE RELATED INFECTION 466 0.0302
726 DEAFNESS 790 0.0302
727 BLOOD BILIRUBIN INCREASED 816 0.0302
728 DYSGEUSIA 2244 0.0302
729 OFF LABEL USE 26432 0.0302
730 ADVERSE EVENT 2776 0.0301
731 SYNCOPE 3008 0.0300
732 EYE HAEMORRHAGE 401 0.0300
733 ANOREXIA 386 0.0299
734 SINUS TACHYCARDIA 424 0.0298
735 INTESTINAL PERFORATION 335 0.0298
736 VISUAL IMPAIRMENT 3697 0.0298
737 GLOMERULAR FILTRATION RATE DECREASED 366 0.0298
738 ABDOMINAL PAIN LOWER 751 0.0297
739 INJECTION SITE RASH 911 0.0297
740 LEUKOPENIA 1481 0.0296
741 HAIR TEXTURE ABNORMAL 396 0.0296
742 INJECTION SITE HAEMORRHAGE 2364 0.0296
743 FEELING ABNORMAL 7086 0.0295
744 INTENTIONAL DOSE OMISSION 840 0.0294
745 SOMNOLENCE 5921 0.0294
746 APHASIA 888 0.0294
747 INJECTION SITE INDURATION 381 0.0294
748 SURGERY 1719 0.0293
749 TREMOR 4861 0.0293
750 COLD SWEAT 516 0.0292
751 INJECTION SITE URTICARIA 718 0.0292
752 HEPATIC CYTOLYSIS 373 0.0292
753 ATAXIA 347 0.0292
754 ORAL DISCOMFORT 406 0.0292
755 NEUTROPHIL COUNT DECREASED 1190 0.0292
756 ACUTE MYOCARDIAL INFARCTION 859 0.0291
757 INJECTION SITE PAIN 8917 0.0290
758 HYPERKALAEMIA 1019 0.0290
759 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1055 0.0290
760 CARDIOMYOPATHY 428 0.0289
761 DIABETES MELLITUS 2206 0.0289
762 HAEMATEMESIS 731 0.0288
763 SPEECH DISORDER 1510 0.0288
764 DYSARTHRIA 1082 0.0287
765 MELAENA 630 0.0286
766 TACHYCARDIA 2530 0.0284
767 TRANSAMINASES INCREASED 633 0.0284
768 PANCREATITIS 1503 0.0284
769 INJECTION SITE SWELLING 2177 0.0284
770 LYMPHOMA 438 0.0283
771 DRUG EFFECT DECREASED 1526 0.0283
772 DEPRESSED MOOD 1490 0.0282
773 IMPAIRED GASTRIC EMPTYING 384 0.0281
774 DEMENTIA 784 0.0280
775 RESPIRATORY FAILURE 2044 0.0280
776 VISION BLURRED 3847 0.0280
777 MULTIPLE FRACTURES 460 0.0280
778 LOSS OF CONSCIOUSNESS 3572 0.0279
779 THERAPEUTIC RESPONSE UNEXPECTED 1249 0.0278
780 ECONOMIC PROBLEM 420 0.0277
781 PANIC ATTACK 1008 0.0276
782 BONE MARROW FAILURE 562 0.0276
783 RASH GENERALISED 714 0.0275
784 NERVOUSNESS 1438 0.0275
785 DRUG EFFECT INCOMPLETE 995 0.0274
786 DRUG INEFFECTIVE 35988 0.0273
787 DISTURBANCE IN ATTENTION 1472 0.0273
788 EYE SWELLING 1015 0.0273
789 ILLNESS 2805 0.0272
790 OCULAR HYPERAEMIA 1284 0.0270
791 DERMATITIS 566 0.0270
792 CARDIAC DISORDER 2526 0.0270
793 THROAT TIGHTNESS 730 0.0270
794 UNEVALUABLE EVENT 2023 0.0267
795 INTERSTITIAL LUNG DISEASE 1293 0.0267
796 POST PROCEDURAL HAEMORRHAGE 309 0.0265
797 HALLUCINATION 2000 0.0265
798 DISORIENTATION 1046 0.0264
799 PRODUCT DOSE OMISSION 1722 0.0264
800 EJECTION FRACTION DECREASED 408 0.0262
801 MULTIPLE ORGAN DYSFUNCTION SYNDROME 742 0.0262
802 INTENTIONAL PRODUCT MISUSE 2284 0.0261
803 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1855 0.0260
804 JAUNDICE 701 0.0260
805 FEBRILE NEUTROPENIA 1726 0.0260
806 PELVIC PAIN 472 0.0260
807 CHOKING 500 0.0256
808 PROSTATIC SPECIFIC ANTIGEN INCREASED 353 0.0256
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4609 0.0255
810 APATHY 373 0.0255
811 UNDERDOSE 1864 0.0255
812 THERAPY INTERRUPTED 1820 0.0254
813 MUSCLE TWITCHING 587 0.0254
814 BLINDNESS UNILATERAL 359 0.0254
815 RESPIRATORY DISTRESS 702 0.0254
816 FEAR 680 0.0253
817 PRODUCT USE IN UNAPPROVED INDICATION 6258 0.0252
818 MULTI-ORGAN FAILURE 436 0.0252
819 HYPERTHYROIDISM 365 0.0252
820 DELUSION 390 0.0251
821 SKIN EXFOLIATION 2111 0.0250
822 HAIR COLOUR CHANGES 311 0.0250
823 NIGHTMARE 864 0.0249
824 EMOTIONAL DISORDER 767 0.0249
825 MENTAL IMPAIRMENT 603 0.0249
826 CRYING 904 0.0248
827 THERAPEUTIC RESPONSE SHORTENED 824 0.0248
828 RASH MACULO-PAPULAR 551 0.0247
829 DYSKINESIA 1006 0.0247
830 LYMPHOPENIA 347 0.0245
831 TREATMENT NONCOMPLIANCE 1342 0.0245
832 LIP SWELLING 816 0.0245
833 ENCEPHALOPATHY 601 0.0244
834 TOXIC EPIDERMAL NECROLYSIS 369 0.0243
835 INCREASED APPETITE 464 0.0243
836 PRODUCT SUBSTITUTION ISSUE 1394 0.0242
837 RENAL IMPAIRMENT 2030 0.0241
838 SKIN REACTION 340 0.0241
839 PULMONARY ARTERIAL HYPERTENSION 349 0.0241
840 VAGINAL HAEMORRHAGE 1044 0.0240
841 MOOD SWINGS 766 0.0240
842 UNRESPONSIVE TO STIMULI 620 0.0240
843 DRUG DOSE OMISSION 3968 0.0240
844 HALLUCINATION, VISUAL 506 0.0239
845 PAIN OF SKIN 645 0.0239
846 SUBDURAL HAEMATOMA 342 0.0239
847 ECZEMA 1249 0.0238
848 EYE IRRITATION 1373 0.0238
849 DRY SKIN 3180 0.0238
850 PHARYNGEAL OEDEMA 366 0.0238
851 RESTLESSNESS 869 0.0237
852 NEUTROPENIA 3219 0.0237
853 ARRHYTHMIA 1121 0.0236
854 HEPATOTOXICITY 527 0.0236
855 THINKING ABNORMAL 440 0.0236
856 COLON CANCER 350 0.0235
857 GAMMA-GLUTAMYLTRANSFERASE INCREASED 519 0.0234
858 MULTIPLE SCLEROSIS 1117 0.0233
859 ABNORMAL DREAMS 645 0.0233
860 PRODUCT DOSE OMISSION IN ERROR 659 0.0232
861 CYANOSIS 365 0.0232
862 HAEMORRHAGE 2407 0.0230
863 EOSINOPHILIA 399 0.0227
864 EYE PRURITUS 762 0.0227
865 SEIZURE 2614 0.0226
866 HYPOACUSIS 969 0.0225
867 ANHEDONIA 591 0.0225
868 GENERALISED TONIC-CLONIC SEIZURE 372 0.0225
869 HUNGER 313 0.0224
870 ANOSMIA 325 0.0224
871 BONE DENSITY DECREASED 702 0.0224
872 CEREBROVASCULAR ACCIDENT 3777 0.0223
873 PERITONITIS 460 0.0222
874 MENORRHAGIA 436 0.0222
875 METASTASES TO BONE 362 0.0220
876 PRODUCT PRESCRIBING ERROR 525 0.0220
877 PANCREATITIS ACUTE 494 0.0220
878 BRADYCARDIA 1165 0.0219
879 DIALYSIS 311 0.0219
880 ANGER 741 0.0219
881 HYPERGLYCAEMIA 792 0.0217
882 PRODUCT DOSE OMISSION ISSUE 6389 0.0217
883 DRUG INTERACTION 3437 0.0216
884 DIABETES MELLITUS INADEQUATE CONTROL 383 0.0216
885 ANAPHYLACTIC REACTION 1191 0.0215
886 PARANOIA 371 0.0215
887 HYPOGLYCAEMIA 1043 0.0215
888 ACNE 1630 0.0215
889 CONVULSION 1229 0.0215
890 PLASMA CELL MYELOMA 836 0.0214
891 RENAL INJURY 636 0.0214
892 BRONCHOSPASM 301 0.0211
893 INJECTION SITE MASS 780 0.0211
894 AGRANULOCYTOSIS 391 0.0210
895 LUNG NEOPLASM MALIGNANT 862 0.0210
896 ACUTE RESPIRATORY DISTRESS SYNDROME 369 0.0208
897 CARDIAC FAILURE 1654 0.0206
898 VENTRICULAR TACHYCARDIA 340 0.0206
899 DEVICE MALFUNCTION 1436 0.0204
900 OSTEONECROSIS OF JAW 503 0.0203
901 BLOOD GLUCOSE DECREASED 973 0.0202
902 MOOD ALTERED 552 0.0202
903 VISUAL ACUITY REDUCED 671 0.0202
904 SEDATION 529 0.0202
905 CIRCULATORY COLLAPSE 344 0.0202
906 MENTAL DISORDER 879 0.0202
907 HOSPITALISATION 3085 0.0201
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 575 0.0200
909 IRRITABILITY 1189 0.0198
910 ERECTILE DYSFUNCTION 506 0.0197
911 DEVICE FAILURE 300 0.0197
912 PRODUCT AVAILABILITY ISSUE 448 0.0197
913 METASTASES TO LIVER 345 0.0196
914 ISCHAEMIC STROKE 350 0.0196
915 MULTIPLE SCLEROSIS RELAPSE 1334 0.0194
916 MYOCARDIAL INFARCTION 3386 0.0194
917 INCORRECT DOSE ADMINISTERED 4428 0.0194
918 PROTEINURIA 368 0.0193
919 DISEASE PROGRESSION 2288 0.0193
920 CEREBRAL HAEMORRHAGE 690 0.0193
921 AGITATION 1412 0.0192
922 PRODUCT USE COMPLAINT 302 0.0192
923 CARDIO-RESPIRATORY ARREST 800 0.0191
924 METABOLIC ACIDOSIS 610 0.0191
925 PRODUCT QUALITY ISSUE 2559 0.0188
926 BLINDNESS 763 0.0187
927 ACCIDENTAL OVERDOSE 682 0.0186
928 SUICIDAL IDEATION 1694 0.0185
929 DEVICE ISSUE 1646 0.0183
930 BLOOD GLUCOSE INCREASED 3432 0.0182
931 DEPRESSED LEVEL OF CONSCIOUSNESS 712 0.0180
932 CARDIAC ARREST 1484 0.0180
933 NEOPLASM PROGRESSION 624 0.0179
934 PRODUCT ADMINISTRATION ERROR 362 0.0179
935 SKIN IRRITATION 820 0.0179
936 COMA 847 0.0178
937 DISEASE RECURRENCE 845 0.0177
938 CARDIOVASCULAR DISORDER 448 0.0176
939 NERVOUS SYSTEM DISORDER 550 0.0176
940 NEEDLE ISSUE 502 0.0172
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 434 0.0172
942 TOOTH LOSS 356 0.0172
943 CHOLESTASIS 328 0.0171
944 INCORRECT PRODUCT ADMINISTRATION DURATION 370 0.0171
945 BLOOD GLUCOSE ABNORMAL 315 0.0170
946 HEPATIC FAILURE 511 0.0169
947 NEOPLASM MALIGNANT 1123 0.0168
948 PSYCHOTIC DISORDER 489 0.0165
949 CEREBRAL INFARCTION 403 0.0165
950 PHARMACEUTICAL PRODUCT COMPLAINT 417 0.0160
951 AGGRESSION 794 0.0158
952 SKIN BURNING SENSATION 1134 0.0158
953 ABNORMAL BEHAVIOUR 627 0.0158
954 MALIGNANT NEOPLASM PROGRESSION 1614 0.0157
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 852 0.0155
956 OSTEONECROSIS 509 0.0155
957 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 361 0.0155
958 INCORRECT DRUG ADMINISTRATION DURATION 429 0.0152
959 STEVENS-JOHNSON SYNDROME 337 0.0151
960 ELECTROCARDIOGRAM QT PROLONGED 541 0.0150
961 DEVICE DISLOCATION 644 0.0148
962 HEPATIC FUNCTION ABNORMAL 538 0.0144
963 RHABDOMYOLYSIS 601 0.0144
964 DRUG ADMINISTRATION ERROR 441 0.0144
965 WITHDRAWAL SYNDROME 601 0.0143
966 APPLICATION SITE PAIN 313 0.0142
967 APPLICATION SITE PRURITUS 300 0.0132
968 APPLICATION SITE ERYTHEMA 344 0.0131
969 OVERDOSE 2813 0.0130
970 ANAPHYLACTIC SHOCK 321 0.0124
971 DEATH 10554 0.0122
972 MENSTRUATION IRREGULAR 324 0.0121
973 EXPIRED PRODUCT ADMINISTERED 402 0.0121
974 RESPIRATORY ARREST 331 0.0120
975 BREAST CANCER 1104 0.0118
976 ANGIOEDEMA 518 0.0117
977 EMOTIONAL DISTRESS 1359 0.0112
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2189 0.0108
979 TOXICITY TO VARIOUS AGENTS 1785 0.0106
980 MYELOSUPPRESSION 372 0.0103
981 LACTIC ACIDOSIS 329 0.0101
982 DERMATITIS ATOPIC 506 0.0096
983 EXTRA DOSE ADMINISTERED 385 0.0095
984 DEVICE LEAKAGE 364 0.0084
985 PROSTATE CANCER 663 0.0082
986 ACCIDENTAL EXPOSURE TO PRODUCT 767 0.0074
987 SUICIDE ATTEMPT 437 0.0072
988 DRUG WITHDRAWAL SYNDROME 536 0.0061
989 NO ADVERSE EVENT 1095 0.0060
990 PRODUCT STORAGE ERROR 526 0.0060
991 DRUG ABUSE 441 0.0053
992 DRUG DEPENDENCE 516 0.0032